Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study.

Mizuno Y, Purcell DW, Zhang J, Knowlton AR, De Varona M, Arnsten JH, Knight KR.

AIDS Behav. 2009 Feb;13(1):165-72. doi: 10.1007/s10461-008-9364-6. Epub 2008 Feb 5.

PMID:
18247113
2.

Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users.

Knowlton A, Arnsten J, Eldred L, Wilkinson J, Gourevitch M, Shade S, Dowling K, Purcell D; INSPIRE Team..

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):486-92.

PMID:
16652058
3.

Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.

Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA.

Drug Alcohol Depend. 2006 Jun 28;83(2):147-56. Epub 2005 Dec 20.

PMID:
16364568
4.
5.
6.

Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico.

Robles RR, Marrero CA, Reyes JC, Colón HM, Matos TD, Finlinson HA, Muñoz A, Meléndez M, Sahai H.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 15;17(5):477-83.

PMID:
9580534
7.

Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.

Buchanan D, Tooze JA, Shaw S, Kinzly M, Heimer R, Singer M.

Drug Alcohol Depend. 2006 Feb 28;81(3):221-9. Epub 2005 Sep 19.

PMID:
16171952
8.

Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection.

McCoy CB, Lai S, Metsch LR, Messiah SE, Zhao W.

Ann Epidemiol. 2004 Sep;14(8):535-42.

PMID:
15350952
9.

The dynamics of injection drug users' personal networks and HIV risk behaviors.

Costenbader EC, Astone NM, Latkin CA.

Addiction. 2006 Jul;101(7):1003-13.

PMID:
16771892
10.

Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.

Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR.

AIDS. 1993 Jun;7(6):887-91.

PMID:
8363764
11.

Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users.

Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA.

J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):86-93.

PMID:
12514419
12.

Incarceration and risk for HIV infection among injection drug users in Bangkok.

Choopanya K, Des Jarlais DC, Vanichseni S, Kitayaporn D, Mock PA, Raktham S, Hireanras K, Heyward WL, Sujarita S, Mastro TD.

J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):86-94.

PMID:
11782595
13.

Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction.

Purcell DW, Metsch LR, Latka M, Santibanez S, Gómez CA, Eldred L, Latkin CA; INSPIRE Study Group..

J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S110-8.

PMID:
15385907
14.

Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.

López-Zetina J, Ford W, Weber M, Barna S, Woerhle T, Kerndt P, Monterroso E.

Sex Transm Infect. 2000 Dec;76(6):462-9.

15.

Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.

Shah NG, Celentano DD, Vlahov D, Stambolis V, Johnson L, Nelson KE, Strathdee SA.

AIDS. 2000 Sep 8;14(13):2035-43.

PMID:
10997409
16.

Microsocial environmental influences on highly active antiretroviral therapy outcomes among active injection drug users: the role of informal caregiving and household factors.

Knowlton AR, Arnsten JH, Gourevitch MN, Eldred L, Wilkinson JD, Rose CD, Buchanan A, Purcell DW; INSPIRE Study Team..

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S110-9. doi: 10.1097/QAI.0b013e31815767f8.

PMID:
18089980
17.

Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto Rico.

Andía JF, Deren S, Kang SY, Robles RR, Colón HM, Oliver-Velez D, Finlinson A, Beardsley M, Friedman SR.

Am J Drug Alcohol Abuse. 2001 Nov;27(4):719-35.

PMID:
11727885
18.

Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions.

Lamster IB, Begg MD, Mitchell-Lewis D, Fine JB, Grbic JT, Todak GG, el-Sadr W, Gorman JM, Zambon JJ, Phelan JA.

Oral Surg Oral Med Oral Pathol. 1994 Aug;78(2):163-74.

PMID:
7936584
19.

HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support.

Chan AC, Palepu A, Guh DP, Sun H, Schechter MT, O'Shaughnessy MV, Anis AH.

J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):56-9.

PMID:
14707793
20.

Correlates of health care utilization among HIV-seropositive injection drug users.

Mizuno Y, Wilkinson JD, Santibanez S, Dawson Rose C, Knowlton A, Handley K, Gourevitch MN; Inspire Team..

AIDS Care. 2006 Jul;18(5):417-25.

PMID:
16777632

Supplemental Content

Support Center